Ads
related to: regulators, diabetes drug- Dosing & Titration
Get Appropriate Dosing
for Patients. Learn More.
- Patient Brochure
Get Resources for Patients
Interested in this T2D Treatment
- Clinical Trial Results
Understand Clinical Trial Data
& Findings. Learn More on Site.
- Co-Pay Card
Cost Savings for Eligible Patients.
Learn More.
- Dosing & Titration
Search results
Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound
Benzinga via Yahoo Finance· 5 days agoEli Lilly And Co (NYSE:LLY) has reportedly reached a settlement agreement with a medi spa that sold...
Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market?
Motley Fool via Yahoo Finance· 1 day agoThey're both based on the same molecule, but regulators approved the product for type 2 diabetes...
Hims debuts $199 weight-loss shots at 85% discount to Wegovy
Detroit News· 1 hour agoIn just a few years, Hims & Hers Health Inc. reached almost $1 billion in sales by making it easy to...
Everything you need to know about semaglutide weight loss drugs
New Scientist· 6 days agoOzempic and Wegovy are brand names for the drug semaglutide. Many countries have approved Wegovy for...
Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
Reuters via Yahoo News· 6 days agoAs part of the deal, Totality Medispa will make a monetary payment to Lilly and will no longer use...
New ‘Godzilla’ weight loss jab is even better than Ozempic, study suggests
The Telegraph via Yahoo News· 7 days ago“We know that tirzepatide (Mounjaro) is the King Kong of the GLP-1s. And when...results in 2026....
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
InvestorPlace· 4 days agoSeveral drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical...
Mizuho still recommends Terns Pharma as a cheap entry to the weight-loss-drug craze
Market Watch· 5 days agoAlthough as it still has no drugs approved by the Food and Drug Administration, incremental updates...
Navigating GLP-1 insurance coverage with the right pharmacy benefits manager
BenefitsPRO· 5 days agoWith the arrival of Ozempic, Wegovy and other GLP-1 agonists, a weight-loss drug boom is sweeping...
2 Top Pharma Stocks That Just Keep Getting Better and Better
Motley Fool via Yahoo Finance· 6 days agoRather than focus on the quantitative changes in medical metrics that the drug caused, it's far more...